Overview
Lobbying Costs
100,000€ - 199,999€
Financial year: Jan 2023 - Dec 2023
Lobbyists (Full time equivalent)
0.1 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Grünenthal GmbH (Grünenthal)
EU Transparency Register
67826544528-01 First registered on 14 Nov 2010
Goals / Remit
Grünenthal is a global leader in pain management and related diseases. As a science-based, privately-owned pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on moving towards our vision of a world free of pain.
As a science-based, privately-owned pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to people living with pain worldwide. Strong ongoing partnerships with leading healthcare and development organisations bring our new products to life. We’re a fully integrated pharmaceutical company that offers support along the entire value chain – from drug development through to commercialisation.
Grünenthal is headquartered in Aachen, Germany, and has affiliates in 29 countries across Europe.Main EU files targeted
Grünenthal's interests in Brussels deal with issues related to health- and pain care, pharmaceuticals, innovation, research and intellectual property. Grünenthal is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and therefore involved in following main legislative proposals and policies:
Pharmaceutical strategy, Review of incentives and rewards, Europe’s Beating Cancer plan, Regulation on Health Technology Assessments, Regulation to create an EU Health Emergency Response Authority (HERA) , Regulation on a European Health Data Space, Cross-border healthcare, Mental Health policyAddress
Head Office
Zieglerstraße, 6
Aachen D-52078
GERMANYEU Office
Zieglerstraße, 6
Aachen D-52078
GERMANYWebsite
-
People
Total lobbyists declared
1
Employment time Lobbyists 10% 1 Lobbyists (Full time equivalent)
0.1
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 20 Apr 2024
Name Start date End Date Ms Gudula Maria Petersen 14 Jun 2018 14 Jun 2019 Mr Theodorus Norbertus Maria van Rooij 17 Oct 2017 17 Oct 2018 Ms Gudula Maria Petersen 12 May 2017 09 May 2018 Mr Theodorus Norbertus Maria van Rooij 10 Oct 2016 05 Oct 2017 Ms Gudula Maria Petersen 29 Apr 2016 29 Apr 2017 Mr Theodorus Norbertus Maria van Rooij 24 Sep 2015 19 Sep 2016 Mr Konrad Labuschagne 21 May 2014 05 Jun 2015 Mr Konrad Labuschagne 25 May 2013 21 May 2014 Mrs Kristina Barinka 02 Mar 2013 29 Mar 2014 Mr Konrad Labuschagne 19 Jun 2012 17 Jun 2013 Mr Theodorus Norbertus Maria van Rooij 24 Mar 2012 01 Dec 2012 Mrs Kristina Barinka 24 Mar 2012 01 Dec 2012 Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
Grünenthal is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA): http://www.efpia.eu as well as of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA): https://www.ifpma.org/ and has signed their respective codes.
Grünenthal is a sponsor the Societal Impact of Pain (SIP) platform. More info can be found here: https://www.sip-platform.euMember organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2023 - Dec 2023
Lobbying costs for closed financial year
100,000€ - 199,999€
Major contributions in closed year
None declared
Intermediaries for closed year
None declaredIntermediaries for current year
None declaredClosed year Costs
100,000€ - 199,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
Societal Impact of Pain (SIP)
Communication activities
Grünenthal is dedicated to creating a better future for pain patients, so getting involved with diverse initiatives that support this goal is vital.
For example, Grünenthal supports the multi-stakeholder platform Societal Impact of Pain (SIP) which initiates projects, arranges events with policy maker and releases position paper on following topics:
- EU Health Policy topics like EU Cancer Plan / Mental Health
- Employment and social integration of patients such as European Pillar of social Rights
- Pain and digital medicine / eHealth / telehealth policies
You find an overview of our initiatives here: https://www.grunenthal.com/about-us/initiativesOther activities
Grünenthal is one of the main sponsors of the European Societal Impact of Pain (SIP) multi-stakeholder platform which is led by the European Pain Federation EFIC and Pain Alliance Europe (Europe) to raise awareness about the impact of pain and to develop policy recommendations for improved pain care.
Meetings
Meetings
None declared